Viewpoint: George Washington University School of Public Health and anti-pesticide economist Charles Benbrook caught in ethics breach

Science for pay? Credit: Stephan Schmitz
Science for pay? Credit: Stephan Schmitz

A recent public release from a graduate student at George Washington University claimed insights from old data answers new questions in newly published research. These new insights claimed they found “high” herbicide exposures which were associated with serious negative health outcomes in women and children – extraordinary and serious claims from a prestigious institution published in a peer-reviewed journal.

However, a review – that both the institution and publisher should have done – shows bias, undisclosed conflicts, clear violations of institutional and publishing ethical standards, and lack of evidence as the hallmarks for these claims. This research does raise new questions – questions for George Washington University and the journal Environmental Health. 

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Benbrook’s reputation has yet to recover from Washington State University’s decision to terminate his last academic contract in the wake of the revelation that Benbrook’s research was solely funded (without disclosure) by organic food industry interests who also happened to be clients of Benbrook’s for-profit consulting firm. In this new GW study, Benbrook fell into old habits. 

Advocacy masquerading as science — denying the findings of both EPA and CDC — is par for the course with Mr. Benbrook and his pesticide litigator and organic industry clients. George Washington University and the Environmental Health journal need to investigate this matter if they wish to preserve a reputation for academic integrity and transparency. 

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Screenshot-2026-05-08-at-3.40.33-PM
Seeds of power: China turns to genetic engineering to become global superpower
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
Screenshot 2026-05-08 at 3.01
Transforming farming and nutrition with AI and robotics? Larry Ellison’s half-billion-dollar Hawaii greenhouse dream goes bust
Farmers can talk to plants
Farmers are a major source of misinformation—about farming
ChatGPT-Image-May-8-2026-01_41_33-PM-3
Viewpoint: Surge of climate misinformation traced to right wing and anti-wind activists 
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.